Evidence map›Paper›PMID 32691334›Full record

ArticleEating and weight disorders : EWD2021

COVID-19 and Hartnup disease: an affair of intestinal amino acid malabsorption.

Enzo Nisoli, Saverio Cinti, Alessandra Valerio

Open access · bronzeAbstract read
In one paragraph

Article in Eating and weight disorders : EWD, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Understanding Renal Tubular Function: Key Mechanisms, Clinical Relevance, and Comprehensive Urine Assessment.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. ACE2, BCurrent opinion in structural biology · 2022
    Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Enzo NisoliDepartment of Biomedical Technology and Translational Medicine, Center for Study and Research on Obesity, University of Milan, Milan, 20129, Italy. enzo.nisoli@unimi.it.ORCID http://orcid.org/0000-0002-6670-1630
Saverio CintiDepartment of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy.
Alessandra ValerioDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, 25123, Italy. alessandra.valerio@unibs.it.
Marche Polytechnic University · ITUniversity of Brescia · ITUniversity of Milan · IT

Funding

Fondazione Cariplo 1006-2016
6 · The paper itself

Abstract

Since the outbreak of COVID-19, clinicians have tried every effort to fight the disease, and multiple drugs have been proposed. However, no proven effective therapies currently exist, and different clinical phenotypes complicate the situation. In clinical practice, many severe or critically ill COVID-19 patients developed gastrointestinal (GI) disturbances, including vomiting, diarrhoea, or abdominal pain, even in the absence of cough and dyspnea. Understanding the mechanism of GI disturbances is warranted for exploring better clinical care for COVID-19 patients. With evidence collected from clinical studies on COVID-19 and basic research on a rare genetic disease (i.e., Hartnup disorder), we put forward a novel hypothesis to elaborate an effective nutritional therapy. We hypothesize that SARS-CoV-2 spike protein, binding to intestinal angiotensin-converting enzyme 2, negatively regulates the absorption of neutral amino acids, and this could explain not only the GI, but also systemic disturbances in COVID-19. Amino acid supplements could be recommended.Level of evidence No level of evidence: Hypothesis article.

Indexed as

Amino AcidsAngiotensin-Converting Enzyme 2COVID-19Gastrointestinal AbsorptionGastrointestinal DiseasesHartnup DiseaseHumansIntestine, SmallPandemicsSARS-CoV-2Spike Glycoprotein, CoronavirusACE2 protein, humanAmino AcidsAngiotensin-Converting Enzyme 2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2ACE2Amino acidsB0AT1COVID-19Gastrointestinal disturbancesHartnup disease

Identifiers

PMID32691334
PMCPMC7369504
OpenAlexW3043382765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.